Mark Stenhouse

Mark Stenhouse

Director/Board Member at PHATHOM PHARMACEUTICALS, INC.

Net worth: 287 700 $ as of 31/05/2026

59 year
Health Technology
Consumer Services

Profile

Mark Stenhouse is currently an Independent Director at Phathom Pharmaceuticals, Inc. since 2020.
Formerly, Mr. Stenhouse was Chief Operating Officer at Prometheus Biosciences, Inc. from 2021 to 2023, General Manager-Screening at EXACT Sciences Corp.
from 2019 to 2021, Director at Prometheus Laboratories, Inc. from 2018 to 2020, Vice President-U.S.
Immunology at AbbVie, Inc. from 2016 to 2018, and Vice President-US Immunology at Abbott Laboratories from 2006 to 2010.
Mr. Stenhouse completed undergraduate education at the College of Charleston.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
19/05/2026 30,000 ( 0.04% ) 287 700 $ 31/05/2026

Latest news about Mark Stenhouse

Mark Stenhouse active positions

CompaniesPositionStart
PHATHOM PHARMACEUTICALS, INC. Director/Board Member 17/03/2020

Former positions of Mark Stenhouse

CompaniesPositionEnd
PROMETHEUS BIOSCIENCES, INC. Chief Operating Officer 16/06/2023
EXACT SCIENCES CORPORATION Corporate Officer/Principal 01/01/2021
Director/Board Member 01/10/2020
ABBVIE INC. Corporate Officer/Principal 01/03/2018
ABBOTT LABORATORIES Corporate Officer/Principal 01/03/2010
See the detail of Mark Stenhouse's experience

Training of Mark Stenhouse

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

61

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies7

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Mark Stenhouse